Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Filing date	Form	Description	View
Feb 09, 2017	4	Statement of changes in beneficial ownership of securities	View HTML 0000899243-17-003297.pdf 0000899243-17-003297.rtf 0000899243-17-003297.xls
Jan 30, 2017	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000215457-17-002178.pdf 0000215457-17-002178.rtf
Jan 09, 2017	8-K	Report of unscheduled material events or corporate event	View HTML 0001558370-17-000061.pdf 0001558370-17-000061.rtf 0001558370-17-000061.xls
Jan 09, 2017	CT ORDER	CT ORDER	View HTML 9999999997-17-000052.pdf
Dec 21, 2016	4	Statement of changes in beneficial ownership of securities	View HTML 0000899243-16-036208.pdf 0000899243-16-036208.rtf 0000899243-16-036208.xls
Dec 15, 2016	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001193805-16-004377.pdf 0001193805-16-004377.rtf 0001193805-16-004377.xls
Dec 08, 2016	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-017106.pdf 0001047469-16-017106.rtf 0001047469-16-017106.xls
Dec 08, 2016	8-K	Report of unscheduled material events or corporate event	View HTML 0001558370-16-010475.pdf 0001558370-16-010475.rtf 0001558370-16-010475.xls
Dec 06, 2016	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-017071.pdf 0001047469-16-017071.rtf 0001047469-16-017071.xls
Dec 05, 2016	8-K	Report of unscheduled material events or corporate event	View HTML 0001558370-16-010368.pdf 0001558370-16-010368.rtf 0001558370-16-010368.xls

Continue